Introduction to Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update

被引：0
作者：
Oskouei, Sonia T. [1 ]
机构：
[1] Cardinal Hlth, Dublin, OH 43017 USA
来源：
AMERICAN JOURNAL OF MANAGED CARE | 2022年 / 28卷 / 12期
关键词：
KNOWLEDGE;
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S215 / S216
页数：2
相关论文
共 11 条
  • [1] Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?
    Baumgart, Daniel C.
    Misery, Laurent
    Naeyaert, Sue
    Taylor, Peter C.
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [2] New Treatments in Rheumatology: Biosimilars
    Brasington, Richard
    Strand, Vibeke
    [J]. CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2020, 6 (04) : 325 - 336
  • [3] Evans C, 2022, AM J MANAG CARE, V28, pS234, DOI 10.37765/ajmc.2022.89298
  • [4] fda, BIOS PROD REG REV AP
  • [5] Gibofsky A, 2022, AM J MANAG CARE, V28, pS227, DOI 10.37765/ajmc.2022.89297
  • [6] US rheumatologists' beliefs and knowledge about biosimilars: a survey
    Gibofsky, Allan
    McCabe, Dorothy
    [J]. RHEUMATOLOGY, 2021, 60 (02) : 896 - 901
  • [7] Competition From Biosimilars Drives Price Reductions For Biologics In The French Single-Payer Health System
    Robinson, James C.
    Jarrion, Quentin
    [J]. HEALTH AFFAIRS, 2021, 40 (08) : 1190 - 1197
  • [8] Biosimilars: Practical Considerations for Pharmacists
    Stevenson, James G.
    Popovian, Robert
    Jacobs, Ira
    Hurst, Susan
    Shane, Lesley G.
    [J]. ANNALS OF PHARMACOTHERAPY, 2017, 51 (07) : 590 - 602
  • [9] Strand V, 2022, AM J MANAG CARE, V28, pS217, DOI 10.37765/ajmc.2022.89296
  • [10] Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States
    Teeple, A.
    Ellis, L. A.
    Huff, L.
    Reynolds, C.
    Ginsburg, S.
    Howard, L.
    Walls, D.
    Curtis, J. R.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (04) : 611 - 617
12